Get notified when ONCO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (worsened) — Cash declined to $5.1M as of Aug 28, 2026 from $5.4M as of Aug 10, 2026, and the company states current cash is not sufficient to fund operations for one year.
Onconetix S-1/A: stock price slides 37% as cash dwindles to $5.1M; going concern persists
Filed August 31, 2026 · Compared to S-1 Aug 12, 2026 · ~1 min read
Key Changes
-
high
Last reported sale price fell 37% to $0.6120 per share between Aug 11 and Aug 28, 2026.
Prospectus Summary verify on EDGAR → -
high
Cash declined to $5.1M as of Aug 28, 2026, and the company says it is not sufficient to fund operations for one year.
Risk Factors verify on EDGAR → -
high
Series C Preferred Stock conversion price was cut from $1.2053 to $0.6087, nearly doubling the underlying share count to 3.3M.
Selling Stockholders view on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ESTC 10-Q) is open in full — no account needed.
Partner
Trade ONCO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 31, 2026 · How we verify